COVID-19 AND NEUROLOGY The aim of this multicenter study was to investigate and characterize the occurrence of olfactory and gustatory disorders in patients with laboratory-confirmed COVID-19 infection. A total of 417 mild-to-moderate COVID-19 patients were included in the study; in… Continue Reading

COVID-19 TREATMENT In this report, the authors describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with remdesivir on a compassionate-use basis. Remdesivir is a prodrug of a nucleotide analogue that is intracellularly metabolized to… Continue Reading

COVID-19 TREATMENT In this nice narrative review just published in JAMA, the authors summarize current evidence regarding major proposed treatments, repurposed or experimental, for COVID-19 and provides a summary of current clinical experience and treatment guidance for this novel epidemic… Continue Reading

Helbok R, Öztürk S On behalf of the Members of the EAN Scientific Panel Neurocritical care Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease are commonly admitted… Continue Reading

My name is Rita and I am a 4th year Neurology resident in a peripheral hospital of northern Portugal, which is located near one of the first COVID-19 pandemic outbreaks in Portugal, the city of Ovar. Although the first case… Continue Reading

In this correspondence, Zhao et al. report the first case of COVID-19 initially presenting with acute Guillain-Barré syndrome (GBS) suggesting a possible association between GBS and SARS-CoV-2 infection. The authors assumed that GBS associated with SARS-CoV-2 might follow the pattern… Continue Reading

In a case series of 214 patients with coronavirus disease 2019 (COVID-19) Mao et al., report that neurologic symptoms were seen in 36.4% of patients and were more common in patients with severe infection (45.5%) according to their respiratory status.… Continue Reading

In this brief report, Poyiadji et al. describe the first presumptive case of COVID-19–associated acute necrotizing encephalopathy (ANE) in a 50-year-old female patient who presented with a 3-day history of cough, fever, and altered mental status. Brain MRI demonstrated haemorrhagic… Continue Reading

This paper addresses the possible proposed neurotropic mechanisms of COVID-19 virus and its analogies and differences with SARS-CoV virus. Indeed, similar to SARS-CoV, COVID-19 virus exploits the angiotensin-converting enzyme 2 (ACE2) receptor to gain entry inside the cells. In particular,… Continue Reading

In this short report, Moriguchi et al., describe the first case of Meningitis/Encephalitis associated with SARS-CoV-2 who was brought in by ambulance. It is very interesting to note that the SARS-CoV-2 RNA was not detected in the nasopharyngeal swab but… Continue Reading

April 10, 2020 The number of subjects infected with SARS-Cov-2 is dramatically increasing worldwide since the beginning of this year. However, as reported in literature so far, only a few SARS-Cov-2–positive children have been admitted to paediatric departments and, generally… Continue Reading

Our country was relatively proactive in the containment measures it took, which meant that there was not a drastic and calamitous increase in the number of people infected and, necessarily, in the number of deaths caused by the virus.

7. April 2020 In patients with Amyotrophic Lateral Sclerosis (ALS), the impact of respiratory infections is expected to be more serious than in the general population, due to the weakness of the respiratory muscles and limitations in coughing (1-4). ALS… Continue Reading

The SARS-CoV-2/COVID-19 pandemic is deeply affecting our health systems both directly and indirectly. In several countries, neurorehabilitation units have had to reduce their bed numbers in order to allow doctors and nurses to work in intensive care units or in… Continue Reading

The EANcore COVID-19 inatitive has launched a survey on neurological symptoms in COVID-19 patients.